APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 62 filers reported holding APTOSE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,976 | -0.2% | 17,200 | +5.5% | 0.00% | – |
Q3 2022 | $10,000 | -33.3% | 16,300 | -17.7% | 0.00% | – |
Q2 2022 | $15,000 | -92.4% | 19,800 | -86.4% | 0.00% | – |
Q4 2021 | $198,000 | -1.0% | 146,110 | +59.5% | 0.00% | – |
Q3 2021 | $200,000 | -39.8% | 91,612 | -8.4% | 0.00% | – |
Q2 2021 | $332,000 | -55.0% | 100,067 | -18.9% | 0.00% | – |
Q1 2021 | $737,000 | -15.1% | 123,400 | -37.9% | 0.00% | – |
Q4 2020 | $868,000 | +114.9% | 198,576 | +194.8% | 0.00% | – |
Q3 2020 | $404,000 | -45.3% | 67,366 | -42.4% | 0.00% | – |
Q2 2020 | $738,000 | -60.7% | 117,048 | -62.9% | 0.00% | – |
Q1 2020 | $1,876,000 | -5.7% | 315,765 | -10.0% | 0.00% | – |
Q4 2019 | $1,990,000 | +354.3% | 350,937 | +66.6% | 0.00% | – |
Q3 2019 | $438,000 | -21.1% | 210,627 | -1.2% | 0.00% | – |
Q2 2019 | $555,000 | +2542.9% | 213,138 | +1961.7% | 0.00% | – |
Q1 2019 | $21,000 | -34.4% | 10,338 | -38.1% | 0.00% | – |
Q4 2018 | $32,000 | -72.9% | 16,695 | -63.3% | 0.00% | – |
Q3 2018 | $118,000 | -31.8% | 45,501 | +3.5% | 0.00% | – |
Q2 2018 | $173,000 | – | 43,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |